AU660125B2 - Phosphonic diester derivative - Google Patents

Phosphonic diester derivative Download PDF

Info

Publication number
AU660125B2
AU660125B2 AU60107/94A AU6010794A AU660125B2 AU 660125 B2 AU660125 B2 AU 660125B2 AU 60107/94 A AU60107/94 A AU 60107/94A AU 6010794 A AU6010794 A AU 6010794A AU 660125 B2 AU660125 B2 AU 660125B2
Authority
AU
Australia
Prior art keywords
group
formula
lower alkyl
phenyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60107/94A
Other languages
English (en)
Other versions
AU6010794A (en
Inventor
Yasuhide Inoue
Yasuo Shoji
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU6010794A publication Critical patent/AU6010794A/en
Application granted granted Critical
Publication of AU660125B2 publication Critical patent/AU660125B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU60107/94A 1993-02-15 1994-02-10 Phosphonic diester derivative Ceased AU660125B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5-25732 1993-02-15
JP2573293 1993-02-15
PCT/JP1994/000209 WO1994018212A1 (en) 1993-02-15 1994-02-10 Phosphonic diester derivative

Publications (2)

Publication Number Publication Date
AU6010794A AU6010794A (en) 1994-08-29
AU660125B2 true AU660125B2 (en) 1995-06-08

Family

ID=12173991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60107/94A Ceased AU660125B2 (en) 1993-02-15 1994-02-10 Phosphonic diester derivative

Country Status (13)

Country Link
US (1) US5480874A (cg-RX-API-DMAC7.html)
EP (1) EP0638581B1 (cg-RX-API-DMAC7.html)
JP (1) JP2926273B2 (cg-RX-API-DMAC7.html)
KR (1) KR100296163B1 (cg-RX-API-DMAC7.html)
CN (1) CN1046733C (cg-RX-API-DMAC7.html)
AT (1) ATE174923T1 (cg-RX-API-DMAC7.html)
AU (1) AU660125B2 (cg-RX-API-DMAC7.html)
CA (1) CA2118007C (cg-RX-API-DMAC7.html)
DE (1) DE69415436T2 (cg-RX-API-DMAC7.html)
DK (1) DK0638581T3 (cg-RX-API-DMAC7.html)
ES (1) ES2126097T3 (cg-RX-API-DMAC7.html)
TW (1) TW260664B (cg-RX-API-DMAC7.html)
WO (1) WO1994018212A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024360A1 (fr) * 1995-12-27 1997-07-10 Otsuka Pharmaceutical Factory, Inc. Derives de diester d'acide phosphonique
US6284748B1 (en) 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
ZA981936B (en) * 1997-03-07 1999-09-06 Metabasis Therapeutics Inc Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
DE60034783T2 (de) 1999-04-22 2008-01-31 H. Lundbeck A/S, Valby Selektive npy(y5)-antagonisten
US6218408B1 (en) 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6989379B1 (en) 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6340683B1 (en) 1999-04-22 2002-01-22 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (triazines)
US6214853B1 (en) 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US7273880B2 (en) 1999-06-30 2007-09-25 H. Lunbeck A/S Selective NPY (Y5) antagonists
US6222040B1 (en) 1999-06-30 2001-04-24 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US6225330B1 (en) 1999-06-30 2001-05-01 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (tricyclics)
US7132438B2 (en) 2001-10-09 2006-11-07 Amgen Inc. Benzimidazole derivatives
JP2005509616A (ja) * 2001-10-16 2005-04-14 センジェント・セラピューティクス・インク チロシンホスファターゼに対する有機硫黄阻害剤
AU2003207589B2 (en) 2002-01-16 2006-07-13 University Of Virginia Patent Foundation 2-Aminothiazole Allosteric Enhancers of A1 Adenosine Receptors
US20060135773A1 (en) * 2004-06-17 2006-06-22 Semple Joseph E Trisubstituted nitrogen modulators of tyrosine phosphatases
WO2006017124A2 (en) * 2004-07-09 2006-02-16 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
MX2007001271A (es) * 2004-08-05 2007-03-21 Hoffmann La Roche N-acil-2-aminotiazoles sustituidos.
WO2006028970A1 (en) * 2004-09-02 2006-03-16 Cengent Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
WO2006040279A1 (de) * 2004-10-07 2006-04-20 Boehringer Ingelheim International Gmbh Pi3-kinasen
WO2006104030A1 (ja) * 2005-03-25 2006-10-05 Daiichi Sankyo Company, Limited チアゾール化合物
TW200712060A (en) * 2005-05-19 2007-04-01 Nissan Chemical Ind Ltd Thiophene compound having phosphoric ester and process for producing the same
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
CN114681454B (zh) * 2022-03-17 2024-05-07 江南大学 噻唑类化合物在制备抗sars-cov-2新型冠状病毒药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
US4434162A (en) * 1981-02-17 1984-02-28 Kanebo, Ltd. Phosphonic acid ester, pharmaceutical compositions containing the same and method of using the same
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JPH0745508B2 (ja) * 1988-06-29 1995-05-17 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
EP0604657B1 (en) * 1992-05-21 2000-01-12 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative

Also Published As

Publication number Publication date
WO1994018212A1 (en) 1994-08-18
KR100296163B1 (ko) 2001-11-05
EP0638581A4 (en) 1995-04-12
DE69415436D1 (de) 1999-02-04
US5480874A (en) 1996-01-02
DE69415436T2 (de) 1999-06-02
EP0638581A1 (en) 1995-02-15
CA2118007A1 (en) 1994-08-18
DK0638581T3 (da) 1999-08-23
CN1102528A (zh) 1995-05-10
ES2126097T3 (es) 1999-03-16
CA2118007C (en) 2003-12-02
JP2926273B2 (ja) 1999-07-28
KR950700917A (ko) 1995-02-20
TW260664B (cg-RX-API-DMAC7.html) 1995-10-21
CN1046733C (zh) 1999-11-24
AU6010794A (en) 1994-08-29
EP0638581B1 (en) 1998-12-23
ATE174923T1 (de) 1999-01-15

Similar Documents

Publication Publication Date Title
AU660125B2 (en) Phosphonic diester derivative
KR0185225B1 (ko) 포스폰산 디에스테르 유도체
DE69624143T2 (de) Phosphonsaurediester-derivate
CA2184891C (en) Phosphonic diester derivative
JPWO1994018212A1 (ja) ホスホン酸ジエステル誘導体
EP0559079B1 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
PL166209B1 (pl) Sposób wytwarzania nowych pochodnych benzimidazolu PL
EP1506190A1 (en) (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
JPWO1993023409A1 (ja) ホスホン酸ジエステル誘導体
US5624918A (en) Phosphonic diester derivatives
CZ386892A3 (en) Novel 2-saccharinylmethyl heterocyclic carboxylates usable as proteolytic enzymes inhibitors and their compositions and method of application
US6468992B1 (en) Phosphonic acid diester derivatives
JPH06228177A (ja) タンパク質分解酵素阻害剤として有用な新規２−サッカリニルメチルホスフェート、ホスホネート及びホスフィネート
EP0666265B1 (en) Phosphonic diester derivative
US4607031A (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
JPS61140593A (ja) 新規ベンジルホスフイン酸エステル誘導体、その製造法およびそれを有効成分とする医薬組成物
GB2394714A (en) Piperidinyl-diarylsilanol compounds and their use in therapy
JPS61236789A (ja) 新規ベンジルホスフイン酸エステル誘導体、その製造法およびそれを有効成分とする医薬組成物